Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.

MLA

González-López, Tomás José, et al. “Fostamatinib Effectiveness and Safety for Immune Thrombocytopenia in Clinical Practice.” Blood, vol. 144, no. 6, Aug. 2024, pp. 646–56. EBSCOhost, https://doi.org/10.1182/blood.2024024250.

APA

González-López, T. J., Bermejo-Vega, N., Cardesa-Cabrera, R., Martínez-Robles, V., Aguilar-Monserrate, G., Pérez-Segura, G., Domingo, A., Luis-Navarro, J., Lakhwani, S., Acedo, N., Lozano, M. L., Bernat, S., Torres-Tienza, A., Ruano, A., Jarque, I., Galán, P., Benet, C., Marcellini, S., Jimenez-Bárcenas, R., … García-Donas Gabaldón, G. (2024). Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice. Blood, 144(6), 646–656. https://doi.org/10.1182/blood.2024024250

Chicago

González-López, Tomás José, Nuria Bermejo-Vega, Rocío Cardesa-Cabrera, Violeta Martínez-Robles, Gerardo Aguilar-Monserrate, Gloria Pérez-Segura, Abel Domingo, et al. 2024. “Fostamatinib Effectiveness and Safety for Immune Thrombocytopenia in Clinical Practice.” Blood 144 (6): 646–56. doi:10.1182/blood.2024024250.